Host cell protein quantification workflow using optimized standards combined with data-independent acquisition mass
Steve Hessmann1, Cyrille Chery2, Anne-Sophie Sikora2
1BioOrganic Mass Spectrometry Laboratory (LSMBO), IPHC UMR 7178, University of Strasbourg, CNRS, ProFI - FR2048, Strasbourg, 67000, France.
Journal of Pharmaceutical Analysis
|June 12, 2023
Summary
Monitoring host cell proteins (HCPs) in monoclonal antibody (mAb) production is crucial for drug safety. A new mass spectrometry workflow using HCP Profiler and DIA achieves sensitive and accurate HCP quantification, supporting biopharmaceutical quality control.
Area of Science:
- Biopharmaceutical manufacturing
- Analytical chemistry
- Protein analysis
Background:
- Host cell protein (HCP) monitoring is vital for monoclonal antibody (mAb) safety and efficacy.
- Traditional ELISA methods for HCP quantification have limitations in protein identification.
- Mass spectrometry (MS) offers a powerful alternative for qualitative and quantitative HCP analysis.
Purpose of the Study:
- To develop and validate a sensitive and robust MS-based workflow for HCP quantification in mAb production.
- To evaluate the performance of the HCP Profiler solution and a data-independent acquisition (DIA) method.
- To establish a standardized analytical method for biopharmaceutical process development and quality control.
Main Methods:
- Implementation of a liquid chromatography-MS (LC-MS) based workflow.
- Utilizing an innovative quantification standard, the HCP Profiler solution.
- Employing a spectral library-based data-independent acquisition (DIA) method with strict data validation.
Main Results:
- The MS-based workflow demonstrated high accuracy and reproducibility (CV < 10%) for HCP quantification.
- Achieved high sensitivity, detecting HCPs down to the sub-ng/mg mAb level.
- The spectral library-based DIA approach outperformed data-dependent acquisition and library-free DIA interpretation.
Conclusions:
- The presented MS-based workflow is a mature and robust method for HCP monitoring in mAb manufacturing.
- This approach supports process development and ensures drug product quality control.
- The HCP Profiler solution and DIA method offer significant advantages over conventional techniques.


